贝瑞基因：2024年净亏损1.92亿元

Core Insights - Berry Genomics (000710) reported a revenue of 1.078 billion yuan for 2024, representing a year-on-year decline of 6.36% [1] - The net loss attributable to shareholders was 192 million yuan, compared to a net loss of 427 million yuan in the same period last year [1] - The basic earnings per share were -0.5443 yuan per share [1] - The company announced plans not to distribute cash dividends, issue bonus shares, or increase capital through reserves [1]